STAAR Surgical | STAA - Selling And Administration Expenses


STAAR Surgical reported $38.64M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Bausch Health Companies USD 901M 88M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 676.2M 303.1M Mar/2026
J&J USD 6.42B 381M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Novartis USD 3.24B 101M Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.64M 299K Mar/2026
Utah Medical Products USD 2.56M 48K Mar/2026